RTX Stock Analysis: RTX | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 288.932m USD | 12M Return: 45.6% | US75513E1010 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 988M
EPS Trend: 99.3%
Qual. Beats: 11
Rev. Trend: 98.9%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
RTX Corporation is a global aerospace and defense company headquartered in Arlington, Virginia, operating through three segments: Collins Aerospace, Pratt & Whitney, and Raytheon. Collins Aerospace provides a wide range of aerospace and defense products and aftermarket services, including flight control systems, cabin interiors, connected aviation solutions, and simulation and training systems for civil, military, and commercial space customers. Pratt & Whitney supplies aircraft engines and auxiliary power units for commercial, military, business jet, and general aviation markets, alongside fleet management and aftermarket maintenance services. Raytheon delivers defensive and offensive threat detection, tracking, and mitigation solutions, including sensors, mission orchestration, satellite control products, and software for government and commercial customers.
The company was originally incorporated in 1934 and was formerly known as Raytheon Technologies Corporation before rebranding to RTX Corporation in July 2023. As a mega-cap stock in the GICS Industrials sector, RTX serves commercial, military, and government customers worldwide, combining propulsion systems, avionics, and defense electronics under one diversified business model.
- Pratt & Whitney GTF inspections pressure margins and free cash flow
- Raytheon missile demand surges on rising global defense budgets
- Collins Aerospace aftermarket recovery drives margin expansion
| Net Income: 7.74b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 5.08 > 1.0 |
| NWC/Revenue: 0.71% < 20% (prev 0.39%; Δ 0.32% < -1%) |
| CFO/TA 0.09 > 3% & CFO 14.8b > Net Income 7.74b |
| Net Debt (32.0b) to EBITDA (16.1b): 1.99 < 3 |
| Current Ratio: 1.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.36b) vs 12m ago 0.79% < -2% |
| Gross Margin: 20.35% > 18% (prev 20.05%; Δ 0.30% > 0.5%) |
| Asset Turnover: 54.82% > 50% (prev 50.02%; Δ 4.80% > 0%) |
| Interest Coverage Ratio: 6.96 > 6 (EBIT TTM 11.7b / Interest Expense TTM 1.68b) |
| A: 0.00 (Total Current Assets 63.9b - Total Current Liabilities 63.2b) / Total Assets 174b |
| B: 0.33 (Retained Earnings 58.0b / Total Assets 174b) |
| C: 0.07 (EBIT TTM 11.7b / Avg Total Assets 171b) |
| D: 0.63 (Book Value of Equity 66.4b / Total Liabilities 106b) |
| Altman-Z'' = 2.23 = BBB |
| DSRI: 1.05 (Receivables 32.9b/28.1b, Revenue 93.5b/83.6b) |
| GMI: 0.99 (GM 20.05% / 20.35%) |
| AQI: 0.93 (AQ_t 0.53 / AQ_t-1 0.56) |
| SGI: 1.12 (Revenue 93.5b / 83.6b) |
| TATA: -0.04 (NI 7.74b - CFO 14.8b) / TA 174b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of August 07, 2026, the stock is trading at USD 223.25 with a total of 5,972,128 shares traded. Over the past week, the price has changed by +4.14%, over one month by +10.87%, over three months by +26.84% and over the past year by +45.62%.
Current recommended Stop Loss: 217.00 (which is 2.8% or 1.2 ATR below the current price).
RTX has received a consensus analysts rating of 4.17. Therefore, it is recommended to buy RTX.
- StrongBuy: 12
- Buy: 4
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 229.8 | 2.9% |
P/E Trailing = 37.8763
P/E Forward = 30.7692
P/S = 3.0902
P/B = 4.3706
P/EG = 2.7703
Revenue TTM = 93.5b USD
EBIT TTM = 11.7b USD
EBITDA TTM = 16.1b USD
Long Term Debt = 31.9b USD (from longTermDebt, last quarter)
Short Term Debt = 5.53b USD (from shortTermDebt, last quarter)
Debt = 40.3b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.47b
Net Debt = 32.0b USD (calculated: Debt 40.3b - CCE 8.30b)
Enterprise Value = 321b USD (289b + Debt 40.3b - CCE 8.30b)
Interest Coverage Ratio = 6.96 (Ebit TTM 11.7b / Interest Expense TTM 1.68b)
EV/FCF = 26.70x (Enterprise Value 321b / FCF TTM 12.0b)
FCF Yield = 3.74% (FCF TTM 12.0b / Enterprise Value 321b)
FCF Margin = 12.85% (FCF TTM 12.0b / Revenue TTM 93.5b)
Net Margin = 8.28% (Net Income TTM 7.74b / Revenue TTM 93.5b)
Gross Margin = 20.35% ((Revenue TTM 93.5b - Cost of Revenue TTM 74.5b) / Revenue TTM)
Gross Margin QoQ = 20.77% (prev 20.81%)
Tobins Q-Ratio = 1.84 (Enterprise Value 321b / Total Assets 174b)
Interest Expense / Debt = 4.16% (Interest Expense 1.68b / Debt 40.3b)
Taxrate = 18.73% (1.87b / 10.00b)
NOPAT = 9.49b (EBIT 11.7b * (1 - 18.73%))
Current Ratio = 1.01 (Total Current Assets 63.9b / Total Current Liabilities 63.2b)
Debt / Equity = 0.61 (Debt 40.3b / totalStockholderEquity, last quarter 66.4b)
Debt / EBITDA = 1.99 (Net Debt 32.0b / EBITDA 16.1b)
Debt / FCF = 2.66 (Net Debt 32.0b / FCF TTM 12.0b)
Total Stockholder Equity = 65.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.54% (Net Income 7.74b / Total Assets 174b)
RoE = 11.80% (Net Income TTM 7.74b / Total Stockholder Equity 65.6b)
RoCE = 11.98% (EBIT 11.7b / Capital Employed (Equity 65.6b + L.T.Debt 31.9b))
RoIC = 8.50% (NOPAT 9.49b / Invested Capital 112b)
WACC = 6.53% (E(289b)/V(329b) * Re(6.97%) + D(40.3b)/V(329b) * Rd(4.16%) * (1-Tc(0.19)))
Discount Rate = 6.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 99.27 | Cagr: 0.91%
[DCF] Terminal Value 77.97% ; FCFF base≈8.43b ; Y1≈9.67b ; Y5≈14.2b
[DCF] Fair Price = 135.1 (EV 214b - Net Debt 32.0b = Equity 182b / Shares 1.35b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.30 | EPS CAGR: 12.49% | SUE: 2.95 | # QB: 11
Revenue Correlation: 98.87 | Revenue CAGR: 12.91% | SUE: 3.20 | # QB: 2
EPS current Quarter (2026-09-30): EPS=1.77 | Chg30d=+2.12% | Revisions=+40% | Analysts=18
EPS current Year (2026-12-31): EPS=7.19 | Chg30d=+3.98% | Revisions=+40% | GrowthEPS=+14.2% | GrowthRev=+8.4%
EPS next Year (2027-12-31): EPS=7.81 | Chg30d=+3.07% | Revisions=+0% | GrowthEPS=+8.7% | GrowthRev=+7.1%
[Analyst] Revisions Ratio: +44% (up=5, down=1)